Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 106

1.

Retrospective analysis of a large patient sample to determine p53 and Ki67 expressions in renal cell carcinoma.

Zheng K, Zhu W, Tan J, Wu W, Yang S, Zhang J.

J BUON. 2014 Apr-Jun;19(2):512-6.

PMID:
24965414
2.

Value of immunohistochemical Ki-67 and p53 determinations as predictive factors of outcome in renal cell carcinoma.

Rioux-Leclercq N, Turlin B, Bansard J, Patard J, Manunta A, Moulinoux JP, Guillé F, Ramée MP, Lobel B.

Urology. 2000 Apr;55(4):501-5.

PMID:
10736491
3.

Prognostic value of carbonic anhydrase IX and KI67 as predictors of survival for renal clear cell carcinoma.

Bui MH, Visapaa H, Seligson D, Kim H, Han KR, Huang Y, Horvath S, Stanbridge EJ, Palotie A, Figlin RA, Belldegrun AS.

J Urol. 2004 Jun;171(6 Pt 1):2461-6.

PMID:
15126876
4.

Ki67 is an independent predictor of oncological outcomes in patients with localized clear-cell renal cell carcinoma.

Gayed BA, Youssef RF, Bagrodia A, Darwish OM, Kapur P, Sagalowsky A, Lotan Y, Margulis V.

BJU Int. 2014 Apr;113(4):668-73. doi: 10.1111/bju.12263. Epub 2013 Aug 13.

5.

Prognostic indicators for renal cell carcinoma: a multivariate analysis of 643 patients using the revised 1997 TNM staging criteria.

Tsui KH, Shvarts O, Smith RB, Figlin RA, deKernion JB, Belldegrun A.

J Urol. 2000 Apr;163(4):1090-5; quiz 1295.

PMID:
10737472
6.

[Multivariate analysis of recurrence and progression in stage T1 transitional-cell carcinoma of the bladder. Prognostic value of p53 and Ki67].

Rodríguez Alonso A, Pita Fernández S, González-Carreró J, Nogueira March JL.

Actas Urol Esp. 2003 Feb;27(2):132-41. Review. Spanish.

PMID:
12731328
7.

The expression of thrombospondin-1 and p53 in clear cell renal cell carcinoma: its relationship to angiogenesis, cell proliferation and cancer specific survival.

Zubac DP, Bostad L, Kihl B, Seidal T, Wentzel-Larsen T, Haukaas SA.

J Urol. 2009 Nov;182(5):2144-9. doi: 10.1016/j.juro.2009.07.015. Epub 2009 Sep 15.

PMID:
19758660
8.

Immunoreactivity of p27(Kip1), cyclin D3, and Ki67 in conventional renal cell carcinoma.

Pertia A, Nikoleishvili D, Trsintsadze O, Gogokhia N, Managadze L, Chkhotua A.

Int Urol Nephrol. 2009;41(2):243-9. doi: 10.1007/s11255-008-9442-8. Epub 2008 Aug 5.

PMID:
18679818
9.

Expression of cyclins A and D and p21(waf1/cip1) proteins in renal cell cancer and their relation to clinicopathological variables and patient survival.

Aaltomaa S, Lipponen P, Ala-Opas M, Eskelinen M, Syrjänen K, Kosma VM.

Br J Cancer. 1999 Aug;80(12):2001-7.

10.

p53 expression in correlation to clinical outcome in patients with renal cell carcinoma.

Ljungberg B, Bozoky B, Kovacs G, Stattin P, Farrelly E, Nylander K, Landberg G.

Scand J Urol Nephrol. 2001 Feb;35(1):15-20.

PMID:
11291681
11.
12.

p53 is an independent predictor of tumor recurrence and progression after nephrectomy in patients with localized renal cell carcinoma.

Shvarts O, Seligson D, Lam J, Shi T, Horvath S, Figlin R, Belldegrun A, Pantuck AJ.

J Urol. 2005 Mar;173(3):725-8.

PMID:
15711252
13.

Prognostic biomarkers in renal cell carcinoma: relevance of DNA ploidy in predicting disease-related survival.

Pinto AE, Monteiro P, Silva G, Ayres JV, Soares J.

Int J Biol Markers. 2005 Oct-Dec;20(4):249-56.

PMID:
16398407
14.

Limited prognostic value of tumor necrosis in patients with renal cell carcinoma.

Isbarn H, Patard JJ, Lughezzani G, Rioux-Leclercq N, Crépel M, Cindolo L, de la Taille A, Zini L, Villers A, Shariat SF, Bertini R, Karakiewicz PI.

Urology. 2010 Jun;75(6):1378-84. doi: 10.1016/j.urology.2009.07.1221. Epub 2009 Sep 25.

PMID:
19781745
15.

Percentage of high-grade carcinoma as a prognostic indicator in patients with renal cell carcinoma.

Serrano MF, Katz M, Yan Y, Kibel AS, Humphrey PA.

Cancer. 2008 Aug 1;113(3):477-83. doi: 10.1002/cncr.23574.

16.

Anillin expression is a marker of favourable prognosis in patients with renal cell carcinoma.

Ronkainen H, Hirvikoski P, Kauppila S, Vaarala MH.

Oncol Rep. 2011 Jan;25(1):129-33.

PMID:
21109967
17.

[Pathological prognostic indicators in renal cell carcinoma].

Rey Rey J, León Ramírez D, López García S, Fernández Vázquez P, Benavente Delgado J, Ojea Calvo A.

Actas Urol Esp. 2010 Jan;34(1):71-7. Spanish.

PMID:
20223135
18.

Prognostic significance of ploidy, MIB-1 proliferation marker, and p53 in renal cell carcinoma.

Kramer BA, Gao X, Davis M, Hall M, Holzbeierlein J, Tawfik O.

J Am Coll Surg. 2005 Oct;201(4):565-70.

PMID:
16183495
19.

Immunohistochemical analysis with multiple antibodies in search of prognostic markers for clear cell renal cell carcinoma.

Phuoc NB, Ehara H, Gotoh T, Nakano M, Yokoi S, Deguchi T, Hirose Y.

Urology. 2007 May;69(5):843-8.

PMID:
17482919
20.

Prognostic value of MCM2 immunoreactivity in stage T1 transitional cell carcinoma of the bladder.

Krüger S, Thorns C, Stöcker W, Müller-Kunert E, Böhle A, Feller AC.

Eur Urol. 2003 Feb;43(2):138-45.

PMID:
12565771
Items per page

Supplemental Content

Write to the Help Desk